Richards Medical Company v. The United States

910 F.2d 828, 1990 U.S. App. LEXIS 13088, 1990 WL 109146
CourtCourt of Appeals for the Federal Circuit
DecidedAugust 3, 1990
Docket89-1693
StatusPublished
Cited by26 cases

This text of 910 F.2d 828 (Richards Medical Company v. The United States) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Richards Medical Company v. The United States, 910 F.2d 828, 1990 U.S. App. LEXIS 13088, 1990 WL 109146 (Fed. Cir. 1990).

Opinion

RICH, Circuit Judge.

The United States Customs Service (Customs) appeals from the June 27, 1989 Judgment of the United States Court of International Trade (CIT), Court No. 84-10-01337, ordering Customs to liquidate certain medical instruments imported by Richards Medical Company (Richards) in accordance with item 960.15 of the Tariff Schedules of the United States (TSUS). The CIT’s opinion is reported at Richards Medical Co. v. United States, 720 F.Supp. 998 (CIT 1989). We affirm.

BACKGROUND

In 1982, Congress passed the Educational, Scientific, and Cultural Materials Importation Act of 1982 1 (the Act), providing for temporary duty-free entry of various merchandise, including “[ajrticles specially designed or adapted for the use or benefit of the blind or other physically or mentally handicapped persons.” This particular exemption from duty was subsequently inserted as items 960.10, 960.12 and 960.15 of the TSUS. Also, as provided by the Act, the following was inserted as Headnote 2 of Part 4 of TSUS Schedule 9:

2. For the purpose of items 960.10, 960.-12, and 960.15—
(a) The term “physically or mentally handicapped persons ” includes any person suffering from a permanent or chronic physical or mental impairment which substantially limits one or more major life activities, such as caring for one’s self, performing manual tasks, walking, seeing, hearing, speaking, breathing, learning, and working.
(b) These items do not cover—
(i) articles for acute or transient disability;
(ii) spectacles, dentures, and cosmetic articles for individuals not substantially disabled;
(iii) therapeutic and diagnostic articles; and
(iv) medicines or drugs.

Richards imported three different kinds of hip prosthesis systems (the Autophor, Spectron, and Xenophor systems), as well as medical instruments specifically designed and sold for use with the different *830 kinds of systems. Customs classified the hip prosthesis systems under item 960.15, TSUS, 2 thus entitling them to duty-free treatment, but classified the instruments under item 709.27, TSUS. 3 Customs denied the subsequent protests by Richards seeking classification of the instruments under item 960.15, on the grounds that they were “therapeutic,” and thus ineligible for classification under item 960.15 by headnote 2(b)(iii). 4

Richards appealed the classification of the instruments to the CIT. Upon review of the statutory language and the limited legislative history, the CIT concluded that the term “therapeutic” in the Act distinguishes articles which are used to heal the condition causing a handicap (therapeutic) from articles which are merely designed to compensate for, or adapt to, the handicapped condition (not therapeutic). Richards Medical, 720 F.Supp. at 1000. The CIT further found that a hip prosthesis does not heal handicapped persons nor cure the disease which caused the handicap, and thus is not therapeutic within the meaning of the Act. Since, concluded the CIT, the medical instruments have no other use than with the prosthesis systems and are used for the benefit of handicapped persons, classification of the instruments under item 960.15 was warranted. Customs appealed.

OPINION

What appears at first to be a single issue — are instruments used to implant hip prostheses therapeutic — is actually two issues: (1) what is the meaning of therapeutic within the context of the Act; and (2) are instruments used to implant hip prostheses within that meaning. The first issue is a question of law subject to review de novo, and the second issue is a question of fact subject to the clearly erroneous standard. Hasbro Industries, Inc. v. United States, 879 F.2d 838, 840 (Fed.Cir.1989).

The first issue, that of the meaning of “therapeutic,” is essentially an issue of statutory construction. As with all questions of statutory construction, we start first with the plain meaning of the statute, and then go to other extrinsic aids such as legislative history if necessary. Johns-Manville Corp. v. United States, 855 F.2d 1556, 1559 (Fed.Cir.1988).

Customs' primary argument with respect to the plain or common meaning of the word “therapeutic” is that it is not limited to treatments which are intended to be curative, but also encompasses treatments which are alleviative or palliative. In support of this argument, Customs relies not only on numerous dictionary and encyclopedia definitions, but also on prior case law involving the meaning of “therapeutic” in other statutes. For example, J.E. Bernard & Co. v. United States, 262 F.Supp. 434, 58 Cust.Ct. 23, 28, C.D. 2872 (1967) indicates that “therapeutic qualities embrace the alleviative or palliative, as well as the curative or healing qualities.”

However, the only conclusion we can reach after reviewing the various definitions from different sources which the parties have provided for us is that the word “therapeutic” has many different meanings and is subject to both broad and narrow interpretations. The question is, which definition best invokes the intent of Congress?

The legislative history is not very helpful on this point. However, one example of an item which is not “therapeutic” is given, and this example definitely cuts against construing this term broadly to include al-leviative or palliative treatments, i.e., treatments which help the handicapped person live with his or her handicapped condition. *831 In particular, the Senate Report accompanying the Act indicates that an automobile fitted with special seats for use by the handicapped or with special attachments to permit a handicapped person to operate the automobile are indicated as being within the scope of the Act. S.Rep. No. 564, 97th Cong., 2d Sess. 20, reprinted in 1982 U.S. Code Cong. & Admin. News 4077, 4097. However, such a specially-equipped automobile is certainly “alleviative” in the sense that it helps the handicapped person to live with the handicap by helping him or her to ride in or drive a car. Thus, to interpret the word “therapeutic” broadly to include “alleviative” would be inconsistent with the one specific example in the legislative history.

In fact, our impression after reading the legislative history is that the CIT drew a very proper distinction in this case. Congress intended to encourage the importation of that merchandise which is designed to compensate for, or help adapt to, the handicapped condition.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Nutricia N. Am., Inc. v. United States
666 F. Supp. 3d 1363 (Court of International Trade, 2023)
Russ Berrie & Co. v. United States
329 F. Supp. 3d 1345 (Court of International Trade, 2018)
Danze, Inc. v. United States
319 F. Supp. 3d 1312 (Court of International Trade, 2018)
Quaker Pet Grp., LLC v. United States
2018 CIT 9 (Court of International Trade, 2018)
Quaker Pet Group, LLC v. United States
287 F. Supp. 3d 1348 (Court of International Trade, 2018)
Kalle USA, Inc. v. United States
273 F. Supp. 3d 1319 (Court of International Trade, 2017)
Sigvaris, Inc. v. United States
227 F. Supp. 3d 1327 (Court of International Trade, 2017)
EOS of North America, Inc. v. United States
911 F. Supp. 2d 1311 (Court of International Trade, 2013)
Victoria's Secret Direct, LLC v. United States
908 F. Supp. 2d 1332 (Court of International Trade, 2013)
Lerner New York, Inc. v. United States
908 F. Supp. 2d 1313 (Court of International Trade, 2013)
Inabata Specialty Chemicals v. United States
366 F. Supp. 2d 1358 (Court of International Trade, 2005)
Warner-Lambert Co. v. United States
341 F. Supp. 2d 1272 (Court of International Trade, 2004)
Norfolk Dredging Co. v. United States
58 Fed. Cl. 167 (Federal Claims, 2003)
Nobelpharma U.S.A. Inc. v. United States
21 Ct. Int'l Trade 47 (Court of International Trade, 1997)
Costa Crociere, S.P.A. v. Rose
939 F. Supp. 1538 (S.D. Florida, 1996)
Anval Nyby Powder AB v. United States
927 F. Supp. 463 (Court of International Trade, 1996)
Marcor Development Corp. v. United States
926 F. Supp. 1124 (Court of International Trade, 1996)
Marubeni America Corp. v. United States
915 F. Supp. 413 (Court of International Trade, 1996)
Trayco, Incorporated v. The United States
994 F.2d 832 (Federal Circuit, 1993)
Travenol Laboratories, Inc. v. United States
813 F. Supp. 840 (Court of International Trade, 1993)

Cite This Page — Counsel Stack

Bluebook (online)
910 F.2d 828, 1990 U.S. App. LEXIS 13088, 1990 WL 109146, Counsel Stack Legal Research, https://law.counselstack.com/opinion/richards-medical-company-v-the-united-states-cafc-1990.